# Aktis Oncology, Inc.: filings

AKTS · Nasdaq · CIK 2035832 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/akts.md) · [Financials](/companies/akts/financials.md) · [Filings](/companies/akts/filings.md) · [Insiders](/companies/akts/insiders.md)

## Reports and events: 14 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 16, 4 13, 144 5, 8-K 5, DRS/A 4, SCHEDULE 13D 3, 10-Q 2, S-1/A 2, 10-K 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, EFFECT 1, S-1 1, S-8 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:05 ET | [10-Q](/filings/0001193125-26-349144.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349144 |
| 2026-08-13 | 16:04 ET | [8-K](/filings/0001193125-26-349133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349133 |
| 2026-05-11 | 16:06 ET | [10-Q](/filings/0001193125-26-216749.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216749 |
| 2026-05-11 | 16:04 ET | [8-K](/filings/0001193125-26-216716.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216716 |
| 2026-04-16 | 16:01 ET | [8-K](/filings/0001193125-26-158944.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-158944 |
| 2026-03-30 | 18:47 ET | [8-K](/filings/0001193125-26-132524.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-132524 |
| 2026-03-30 | 17:29 ET | [10-K](/filings/0001193125-26-131748.md) | Annual report, period 2025-12-31 | 0001193125-26-131748 |
| 2026-01-20 | 17:44 ET | [SCHEDULE 13D](/filings/0001231919-26-000070.md) | Ownership report, active investor | 0001231919-26-000070 |
| 2026-01-20 | 14:01 ET | [SCHEDULE 13D](/filings/0000935836-26-000046.md) | Ownership report, active investor | 0000935836-26-000046 |
| 2026-01-14 | 16:58 ET | [SCHEDULE 13D](/filings/0001193125-26-013015.md) | Ownership report, active investor | 0001193125-26-013015 |
| 2026-01-12 | 16:03 ET | [8-K](/filings/0001193125-26-010354.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-010354 |
| 2026-01-07 | 07:19 ET | [S-1/A](/filings/0001193125-26-005437.md) | Registration statement, amended | 0001193125-26-005437 |
| 2026-01-05 | 06:31 ET | [S-1/A](/filings/0001193125-26-001466.md) | Registration statement, amended | 0001193125-26-001466 |
| 2025-12-19 | 16:02 ET | [S-1](/filings/0001193125-25-326780.md) | Registration statement | 0001193125-25-326780 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.